Evidence map›Paper›PMID 18414844›Full record

ReviewEuropean biophysics journal : EBJ2009

Inhibition of P2X(7) receptors by divalent cations: old action and new insight.

Lin-Hua Jiang

Abstract readReview
PubMed Publisher
In one paragraph

Review in European biophysics journal : EBJ, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. P2XFrontiers in cellular neuroscience · 2021
    Review
  7. P2X7 Receptor at the Crossroads of T Cell Fate.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Progress in Sympathetically Mediated Pathological Pain.Journal of anesthesia and perioperative medicine · 2015
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Lin-Hua JiangInstitute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leed LS29JT, UK. l.h.jiang@leeds.ac.uk
University of Leeds · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

P2X family receptors form ATP-gated ion channels by assembling homo/hetero-trimers from seven receptor subunits. The homomeric P2X(7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and copper. Despite the fact that this distinct feature was first described almost three decades ago, our understanding is still contentious. Recent site-directed mutagenesis studies have provided direct evidence showing that functional inhibition by zinc and copper primarily results from direct interaction with the receptor. In this short review, I will give a concise description of the major localization, biological functions, and unique properties of the P2X(7) receptor, and particularly discuss the evolving understanding of how divalent cations inhibit the P2X(7) receptor and the potential implication of such inhibition to the physiological and pathophysiological role of the P2X(7) receptor.

Indexed as

AnimalsCations, DivalentHumansIon Channel GatingReceptors, Purinergic P2Receptors, Purinergic P2X7Cations, DivalentP2RX7 protein, humanReceptors, Purinergic P2Receptors, Purinergic P2X7

Identifiers

PMID18414844
OpenAlexW2036199192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.